| Long-Term Benzodiazepine Use and Mortality: Are we Doing the Right Studies? | |
| | |
MedLine Citation:
|
PMID: 23373552 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Benzodiazepines are World Health Organisation essential medicines used in the treatment of alcohol withdrawal, anaesthesia, sedation, anxiolysis, behavioural disturbance, epilepsy, insomnia, palliative care, and muscle spasm. Despite their widespread use concerns remain over their long-term safety through both neuronal and non-neuronal effects. We conducted a systematic review to identify vulnerable populations of patients who may be at increased risk of harm from benzodiazepines. We identified three potentially "at risk" groups of patients, those with renal disease, lung disease and those recently hospitalised. However methodological limitations including selection bias, vague descriptors of benzodiazepine use and inappropriate grouping together of benzodiazepines with other medications, precluded definitive conclusions. Future studies should concentrate on these groups to identify the long-term safety of benzodiazepines in these patient groups. |
| | |
Authors:
|
Robert David Sanders |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-2-01 |
Journal Detail:
|
Title: Current drug safety Volume: - ISSN: 2212-3911 ISO Abbreviation: Curr Drug Saf Publication Date: 2013 Feb |
Date Detail:
|
Created Date: 2013-2-4 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101270895 Medline TA: Curr Drug Saf Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Wellcome Department of Imaging Neuroscience, Institute of Cognitive Neuroscience, University College London, London, WC1N 3AR, UK. r.sanders@ucl.ac.uk. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Toxic Epidermal Necrolysis.
Next Document: Prospective Evaluation of the Dosing Regimen of Vancomycin in Children of Different Weight Categorie...